Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Benefits of agomelatine in behavioral, neurochemical and blood brain barrier alterations in prenatal valproic acid induced autism spectrum disorder
Hariom Kumar, B.M. Sharma, Bhupesh Sharma
Neurochemistry International (2015) Vol. 91, pp. 34-45
Closed Access | Times Cited: 70

Showing 1-25 of 70 citing articles:

Blood-brain barrier regulation in psychiatric disorders
John Kealy, Chris Greene, Matthew Campbell
Neuroscience Letters (2018) Vol. 726, pp. 133664-133664
Open Access | Times Cited: 238
A Systematic Review of the Valproic-Acid-Induced Rodent Model of Autism
Devahuti R. Chaliha, Matthew A. Albrecht, Mauro Vaccarezza, et al.
Developmental Neuroscience (2020) Vol. 42, Iss. 1, pp. 12-48
Open Access | Times Cited: 124
Targeting anandamide metabolism rescues core and associated autistic-like symptoms in rats prenatally exposed to valproic acid
Michela Servadio, Francesca Melancia, Antonia Manduca, et al.
Translational Psychiatry (2016) Vol. 6, Iss. 9, pp. e902-e902
Open Access | Times Cited: 118
The Free-movement pattern Y-maze: A cross-species measure of working memory and executive function
Madeleine Cleal, Bárbara D. Fontana, Daniel C. Ranson, et al.
Behavior Research Methods (2020) Vol. 53, Iss. 2, pp. 536-557
Open Access | Times Cited: 90
Emerging mechanisms of valproic acid-induced neurotoxic events in autism and its implications for pharmacological treatment
Abdoh Taleb, Wen Lin, Xiang Xu, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 137, pp. 111322-111322
Open Access | Times Cited: 65
From Neurodevelopmental to Neurodegenerative Disorders: The Vascular Continuum
Julie Ouellette, Baptiste Lacoste
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 55
Memantine ameliorates autistic behavior, biochemistry & blood brain barrier impairments in rats
Hariom Kumar, Bhupesh Sharma
Brain Research Bulletin (2016) Vol. 124, pp. 27-39
Closed Access | Times Cited: 77
Benefits of Fenofibrate in prenatal valproic acid-induced autism spectrum disorder related phenotype in rats
Roohi Mirza, Bhupesh Sharma
Brain Research Bulletin (2019) Vol. 147, pp. 36-46
Closed Access | Times Cited: 64
Pathophysiological Studies of Monoaminergic Neurotransmission Systems in Valproic Acid-Induced Model of Autism Spectrum Disorder
Hsiao‐Ying Kuo, Fu‐Chin Liu
Biomedicines (2022) Vol. 10, Iss. 3, pp. 560-560
Open Access | Times Cited: 28
Three Decades of Valproate: A Current Model for Studying Autism Spectrum Disorder
David Zárate-López, Ana Laura Torres-Chávez, Alma Y. Gálvez‐Contreras, et al.
Current Neuropharmacology (2023) Vol. 22, Iss. 2, pp. 260-289
Open Access | Times Cited: 19
Impaired repair of DNA damage is associated with autistic-like traits in rats prenatally exposed to valproic acid
Michela Servadio, Antonia Manduca, Francesca Melancia, et al.
European Neuropsychopharmacology (2017) Vol. 28, Iss. 1, pp. 85-96
Closed Access | Times Cited: 51
Prenatal Exposure to Valproic Acid Affects Microglia and Synaptic Ultrastructure in a Brain-Region-Specific Manner in Young-Adult Male Rats: Relevance to Autism Spectrum Disorders
Magdalena Gąssowska-Dobrowolska, Magdalena Cieślik, Grzegorz A. Czapski, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 10, pp. 3576-3576
Open Access | Times Cited: 48
Autism spectrum disorder (ASD): Disturbance of the melatonin system and its implications
Zhouyue Wu, Shu‐dai Huang, Jin-jun Zou, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 130, pp. 110496-110496
Open Access | Times Cited: 46
Prevention or Amelioration of Autism-Like Symptoms in Animal Models: Will it Bring Us Closer to Treating Human ASD?
Asher Ornoy, Liza Weinstein‐Fudim, Zivanit Ergaz
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 5, pp. 1074-1074
Open Access | Times Cited: 45
Social isolation after chronic unpredictable mild stress perpetuates depressive-like behaviors, memory deficits and social withdrawal via inhibiting ERK/KEAP1/NRF2 signaling
Lujia Si, Ling Xiao, Yinping Xie, et al.
Journal of Affective Disorders (2022) Vol. 324, pp. 576-588
Open Access | Times Cited: 22
Valproate-Induced Model of Autism in Adult Zebrafish: A Systematic Review
Diletta Camussi, Maria Marchese, Ferdinando Nicoletti, et al.
Cells (2025) Vol. 14, Iss. 2, pp. 109-109
Open Access
Plasma vinculin, β-catenin, E-cadherin levels in children with autism spectrum disorder
Havvanur Eroğlu Doğan, Ümit Işık, Halil İbrahim Büyükbayram
International Journal of Developmental Disabilities (2025), pp. 1-8
Closed Access
Molecular Pathology and Pharmacological Treatment of Autism Spectrum Disorder-Like Phenotypes Using Rodent Models
Hsiao‐Ying Kuo, Fu‐Chin Liu
Frontiers in Cellular Neuroscience (2018) Vol. 12
Open Access | Times Cited: 46
Selective modulator of peroxisome proliferator-activated receptor-α protects propionic acid induced autism-like phenotypes in rats
Roohi Mirza, Bhupesh Sharma
Life Sciences (2018) Vol. 214, pp. 106-117
Closed Access | Times Cited: 44
Attenuation of neurobehavioural abnormalities by papaverine in prenatal valproic acid rat model of ASD
Kanishk Luhach, Giriraj T. Kulkarni, Vijay Pal Singh, et al.
European Journal of Pharmacology (2020) Vol. 890, pp. 173663-173663
Closed Access | Times Cited: 36
Vinpocetine amended prenatal valproic acid induced features of ASD possibly by altering markers of neuronal function, inflammation, and oxidative stress
Kanishk Luhach, Giriraj T. Kulkarni, Vijay Pal Singh, et al.
Autism Research (2021) Vol. 14, Iss. 11, pp. 2270-2286
Closed Access | Times Cited: 31
Potential crosstalk between sonic hedgehog‐WNT signaling and neurovascular molecules: Implications for blood–brain barrier integrity in autism spectrum disorder
Evelyne Gozal, Rekha Jagadapillai, Jun Cai, et al.
Journal of Neurochemistry (2021) Vol. 159, Iss. 1, pp. 15-28
Open Access | Times Cited: 29
Probiotics and prebiotics alleviate behavioral deficits, inflammatory response, and gut dysbiosis in prenatal VPA-induced rodent model of autism
Emre Adıgüzel, Betül Çiçek, Gökhan Ünal, et al.
Physiology & Behavior (2022) Vol. 256, pp. 113961-113961
Closed Access | Times Cited: 20
Agomelatine: A Potential Multitarget Compound for Neurodevelopmental Disorders
Rosa Savino, Anna Nunzia Polito, Gabriella Marsala, et al.
Brain Sciences (2023) Vol. 13, Iss. 5, pp. 734-734
Open Access | Times Cited: 12
Agomelatine reduces brain, kidney and liver oxidative stress but increases plasma cytokine production in the rats with chronic mild stress-induced depression
Arif Demirdaş, Mustafa Nazıroğlu, Güli̇n Özdamar Ünal
Metabolic Brain Disease (2016) Vol. 31, Iss. 6, pp. 1445-1453
Closed Access | Times Cited: 35
Page 1 - Next Page

Scroll to top